ÂÜÀòÂÒÂ×

Erica Ragazzo is a Senior Accountant at Arbor Biotechnologies since November 2022, contributing to the company's innovative approach in the life sciences sector through the use of advanced technologies. Previously, Erica held the position of Senior Accountant at Forma Therapeutics from June 2022 until the company's acquisition by Novo Nordisk in October 2022, and at Imara Inc. from August 2020 to May 2022. Erica's experience in public accounting was further developed during tenure at EY from 2016 to 2020, progressing from an Assurance Intern to Assurance Senior, with a focus on clients in the biotechnology industry. Erica earned a Bachelor of Science in Accounting from Saint Michael's College between 2013 and 2017, following graduation from Ursuline Academy in 2013.